Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
202.00
USD
-2.14 (-1.05%)
Official Closing Price
Updated: 4:19 PM EST, Mar 3, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Leerink Presents: Your 2017 Biopharma Catalyst Tracker
March 20, 2017
In its biopharma catalysts tracker released March 1, Leerink termed the year 2017 as a busy one for Neuro and Oncology. The firm ...
Tags
MRK
SHPG
REGN
From
Benzinga
UPDATE 1-Lilly's breast cancer drug combination succeeds key study
March 20, 2017
March 20 (Reuters) - Eli Lilly and Co said a combination of its experimental breast cancer drug and another widely used treatment slowed disease progression in a key study in patients who had relapsed...
Tags
companyNews
From
Reuters: Company News
BRIEF-Lilly says phase 3 breast cancer study meets primary endpoint
March 20, 2017
* Lilly announces phase 3 monarch 2 breast cancer study of abemaciclib met primary endpoint of progression-free survival
Tags
companyNews
From
Reuters: Company News
REFILE-Newer type 2 diabetes drugs show heart protective quality in study
March 19, 2017
WASHINGTON, March 19 (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease,...
Tags
companyNews
From
Reuters: Company News
Cramer's lightning round: Target's caught between these two retailers, and it could get hairy
March 17, 2017
Jim Cramer sped through his takes on caller favorite stocks, including Target, which is in a tough spot.
Tags
Investing/Stock Market
Investing
Eli Lilly and Co
From
CNBC.com News
BRIEF-First dedicated outcome trials of empagliflozin in chronic heart failure initiated
March 17, 2017
* First dedicated outcome trials of Empagliflozin in chronic heart failure initiated
Tags
companyNews
From
Reuters: Company News
IWV, PCLN, CVS, LLY: Large Outflows Detected at ETF
March 16, 2017
Symbols mentioned in this story: IWV, PCLN, CVS, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Here's Why Aratana Therapeutics Inc. Is Getting Clobbered
March 14, 2017
Tags
LLY
PETX
From
Motley Fool
Pfizer Inc. Suddenly Faces Stiff Breast Cancer Drug Competition From Novartis
March 14, 2017
Pfizer Inc. had been just the only player in a very specific breast cancer treatment game, but now Novartis has entered the race with a brand new drug that could be a blockbuster and threaten Pfizer’s...
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Better Buy: Eli Lilly and Company vs. Pfizer
March 13, 2017
Tags
LLY
PFE
From
Motley Fool
Lilly, Merck, Allergan Top Analyst's View For 2017 Pharma
March 13, 2017
Eli Lilly, Merck and Allergan stand to outperform broad pharma stocks in 2017, a Credit Suisse analyst said Monday.
Tags
Technology
From
Investor's Business Daily
How Incyte Stock Became a Bull Market Star for Biotech Investors
March 10, 2017
Despite many twists and turns, the U.S. stock market has had a stupendous run since it reached a bottom in Mar 2009. The bull run has continued for eight years with the S&P 500 gaining 198.1% during...
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Incyte Corporation at the Cowen Healthcare Conference: 4 Things You'll Want to Know
March 09, 2017
Tags
INCY
MRK
LLY
From
Motley Fool
Feds cause standstill for promising marijuana cure for Alzheimer's
March 09, 2017
Promising new research suggests that marijuana could be used to treat Alzheimer's, but there's a major roadblock: the federal government.
Tags
Health Care
Health Care/Pharmaceuticals Biotechnology and Life Sciences
Biotechnology
From
CNBC.com News
This Pharma Firm Is Beating The Pack In Getting Drugs To Market
March 08, 2017
Lilly's pipeline has the best "bang-for-the-buck," Leerink said Wednesday, pitting Lilly against larger rivals Pfizer, Merck and Bristol.
Tags
Technology
From
Investor's Business Daily
INSIGHT-"It's like kumbaya:" Trump's genial private meetings with CEOs jar with public attacks
March 07, 2017
WASHINGTON, March 8 (Reuters) - When the bosses of some of the world's largest pharmaceutical companies headed to Washington in January to meet U.S. President Donald Trump, it had all the makings of a...
Tags
companyNews
From
Reuters: Company News
Trump’s ‘Obamacare Lite’ presents opportunities and perils for investors
March 07, 2017
Health-care insurers and medical-device companies would benefit. Also, expect a wave of M&A, writes Nigam Arora.
Tags
BSX
DIA
VNDA
From
MarketWatch
PPH, LLY, GSK, SNY: Large Outflows Detected at ETF
March 06, 2017
Symbols mentioned in this story: PPH, LLY, GSK, SNY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Week In Review: OrbiMed Plans $450 Million Target For Third Asia Life Science Fund
March 04, 2017
OrbiMed filed with the SEC to raise $450 million for its third Asia-focused fund, OrbiMed Asia Partners III. The company says it considers investments in all sectors of life science.
Tags
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Chi-Med's Lead Candidate Passes Phase III Colorectal Cancer Test
March 02, 2017
Hutchison China MediTech (Chi-Med) reported that its lead drug, fruquintinib, met its endpoints in a pivotal Phase III China trial. Fruquintinib was tested as a third-line treatment for metastatic...
From
ChinaBio® Today
BRIEF-Eli Lilly says senior VP of corporate affairs and communications to leave
March 01, 2017
* Eli Lilly and Co - Johna Norton will be promoted to senior vice president of global quality April 1, replacing Fionnuala Walsh
Tags
companyNews
From
Reuters: Company News
Cramer’s charts uncover 4 pharma stocks ready to explode higher
March 01, 2017
Jim Cramer went off the charts with Bob Lang to determine if pharma has more room to run.
Tags
Eli Lilly and Co
Investing
Investing/Stock Market
From
CNBC.com News
Icahn, after break from biopharma activism, hires Harvard geneticist Richard Mulligan
March 01, 2017
The hire signals Carl Icahn may be back to biopharma investing, at a time when biotech valuations are 25 percent off their 2015 highs.
Tags
People/Newsmakers/Carl Icahn
Health Care
Biotechnology
From
CNBC.com News
BRIEF-Perrigo announces FDA final approval for the generic version of Axiron topical solution
March 01, 2017
* Perrigo announces FDA final approval for the generic version of Axiron topical solution, 30 mg/1.5 ml Source text for Eikon: Further company coverage:
Tags
companyNews
From
Reuters: Company News
Accera's Alzheimer's trial fails, in yet another setback for disease
February 28, 2017
Feb 28 (Reuters) - Nestle SA-backed Accera Inc said on Tuesday its experimental Alzheimer's drug failed a late-stage study, adding to the laundry list of disappointments in the pursuit of an effective...
Tags
companyNews
From
Reuters: Company News
Roche to start new trial of AC Immune drug against Alzheimer's
February 27, 2017
ZURICH, Feb 28 (Reuters) - Roche is starting a second late-stage trial of investigational Alzheimer's drug crenezumab that it is developing with Swiss biotech AC Immune , shrugging off failures of...
Tags
companyNews
From
Reuters: Company News
Overview of Vanguard Capital Opportunity Investor Fund (VHCOX)
February 26, 2017
Vanguard Capital Opportunity Investor invests primarily in stocks of mid- and small-capitalization companies expected to have above-average earnings growth.
Tags
Healthcare
Stocks / Equities
Mutual Funds
From
Blogs - TalkMarkets
Better Buy: Eli Lilly and Co vs. GlaxoSmithKline plc
February 25, 2017
Tags
GSK
LLY
From
Motley Fool
BRIEF-FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi
February 24, 2017
* U.S. FTC - Approved final order settling charges that Boehringer Ingelheim’s $13.53 billion asset swap with Sanofi would likely be anticompetitive Source text : (http://bit.ly/2lC10ws) Further...
Tags
companyNews
From
Reuters: Company News
Carl Icahn's Track Record In Big Pharma
February 24, 2017
Billionaire investor and corporate raider Carl Icahn has trained his eyes on Bristol-Myers Squibb Co (NYSE: BMY). A Wall Street ...
Tags
General
News
RHHBY
From
Benzinga
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.